1 / 22

Blood

Blood. Week 7 Dr. Walid Daoud A. Professor. Anemia ____________________________. Anemia is decrease in O2 carrying capacity of blood due to: 1- Decreased number of RBCs: . Less than 4.5 million/mm 3 in males. . Less than 3.9 million/mm 3 in females.

alisa
Download Presentation

Blood

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Blood Week 7 Dr. Walid Daoud A. Professor

  2. Anemia____________________________ Anemia is decrease in O2 carrying capacity of blood due to: 1- Decreased number of RBCs: . Less than 4.5 million/mm3 in males. . Less than 3.9 million/mm3 in females. 2- Decreased Hb content of blood: . Less than 13.5 g/dl in males. . Less than 11.5 g/dl in females.

  3. Classification & Causes of Anemia_____________________________ According to size of RBCs & Hb content: I-Normocytic Normochromic Anemia: Both size of RBCs & Hb content are normal but RBCs number is decreased. Causes: -Acute blood loss (Hemorrhagic anemia). -Bone marrow depression (Aplastic anemia). -Breakdown of RBCs(Hemolytic anemia).

  4. Classification & Causes of Anemia____________________________ II-Microcytic Hypochromic Anemia or Iron Deficiency Anemia: Both size of RBCs and Hb contents are less than normal. Causes: -Decreased iron intake in diet. -Failure of iron absorption. -Chronic blood loss.

  5. Classification & Causes of Anemia_____________________________ III-Macrocytic Hyperchromic Anemia or Megaloblastic Anemia: Both size of RBCs and Hb content are more than normal. Causes: -Vitamin B12 deficiency. -Folic acid deficiency.

  6. Platelets or Thrombocytes____________________________ Non-nucleated, granulated bodies, 2-4 µm in diameter. Normal platelet count: 150,000-450,000/mm3 Decreased platelet count (Thrombocytopenia). Increased platelet count (Thrombocytosis).

  7. Formation of Platelets____________________________ Pluripotential stem cell in bone marrow ↓ interleukin CFU-M ↓ GM-CSF Megakaryocyte ↓thrombopoietin Platelets CFU-M = Colony forming unit-megakayocyte. GM-CSF=Granulocye-monocyte colony stimulating factor.

  8. Structure of Platelets___________________________ A. Platelet membrane. B. Platelet cytoplasm: 1- Beneath membrane: microtubules & ptn. 2- Intracellular organelles: 3- Glycogen granules. 4- Enzymes for synthesis of prostaglandins. 5- Granules: . Dense granules. . Alpha granules.

  9. Hemostasis___________________________ It means stoppage of bleeding from an injured blood vessel. Hemostatic process consists of: I- Local vasoconstriction of injured blood vessel. II- Temporary hemostatic plug formation. III-Blood clot formation.

  10. Hemostasis___________________________ I- Local vasoconstriction: 1- Nervous reflex. Initiated by pain sensation. 2- Local myogenic contraction. Due to direct damage of blood vessels. 3- Chemical substances. Serotonin and thromboxane A2 liberated from platelets cause vasoconstriction.

  11. Hemostasis___________________________ II- Temporary Hemostatic Plug Formation: 1- Platelet adhesion. 2- Platelet activation. 3- Release reaction. 4- Platelet aggregation. 5- Platelet procoagulant activity. 6- Platelet fusion.

  12. Hemostasis___________________________ III- Blood Coagulation (Blood Clotting): Properties of Blood Coagulation Factors:

  13. Hemostasis___________________________ The clotting mechanism: The loose platelet plug changes to blood clot: 1-Fibrinogen forms a loose then tight fibrin clot catalyzed by factor XIII and Ca2+. 2-Thrombin converts fibrinogen to fibrin. 3-Active factor X converts prothrombin to thrombin. 4-Factor X is activated by either extrinsic or intrinsic pathways.

  14. Hemostasis___________________________ A. Intrinsic Pathway: In vivo (in plasma) or in vitro (glass of tube). - Activation of factor XII by HMW kininogen and kallikrein in plasma. - XIIa activates factor XI. - XIa activates factor IX. - IXa forms a complex with VIIIa & activates factor X in presence of phospholipids (PF3) and Ca2+.

  15. Hemostasis___________________________ B- Extrinsic Pathway: Initiated only in vivo by tissue thromboplastin (TPL, factor III); they are group of tissue phospholipoprotein released from damaged vascular and connective tissues. - TPL activates factor VII. - VIIa directly activates factor X in presence of Ca2+ TPL and phospholipids (PL) and indirectly through activation of factor IX.

  16. Hemostasis___________________________ Common Part in Both Pathways: - Xa converts prothrombin to thrombin. - Thrombin transforms soluble fibrin to insoluble fibrin. - Thrombin in presence of Ca2+ activates factor XIII which stabilizes fibrin clot. - Contraction of actin, myosin and thrombosthenin of platelets causes clot retraction and squeezes serum out.

  17. Hemostasis___________________________ Important notes: - Extrinsic pathway is very rapid (15 sec.) while intrinsic pathway is slow (1-6 min.). - Injury of a blood vessel will trigger both the intrinsic system by exposed collagen and extrinsic system by tissue thromboplastin. - In test tube, clotting occurs only by intrinsic system by glass or addition of collagen. - In intravenous thrombosis, clotting occurs via intrinsic system by exposure of clotting factors to subendothelial collagen.

  18. Anticoagulant Mechanisms____________________________ Limiting reactions: prevent blood clotting in healthy blood vessels and breakdown any clots already formed. A.General:1-Smooth vascular endothelium. 2- Rapid flow of blood. 3- Heparin. B.Specific:1-Thromboxane A2 & Prostacyclin. 2- Antithrombin III. 3- Fibrinolytic system.

  19. The Fibrinolytic System____________________________ Thrombomodulin binds thrombin to form thrombomodulin-thrombin system which activate protein C which causes: -Inactivation of factor Va and VIIIa. -Inactivation of inhibitor of tissue plasminogen activator (t-PA), ↑ formation of plasmin. Plasmin (fibrinolysin) is an enzyme formed from plasminogen. It lyses fibrin & fibrinogen forming fibrin-degradation products (FDP) which inhibits thrombin.

  20. Anticoagulants____________________________ Substances used to prevent blood clotting. A- In vitro anticoagulants: in a test tube: 1-Removal of Ca2+ : . Oxalates: precipitates Ca2+ . . Citrates: binds Ca2+ by deionizing them 2-Silicon: prevents activation of factor XII. 3-Heparin.

  21. Anticoagulants____________________________ B- In vivo anticoagulants: inside the body:

  22. Abnormalities of Hemostasis____________________________ 1-Thrombocytopenic purpura: S.C. hemorrhage - ↓ Platelets count below 50,000 / mm3 . - Bleeding time is prolonged.. 2-Vitamin K deficiency: due to: -Decreased formation: absent intestinal flora. -Decreased absorption: bile duct obstruction. 3-Hemophilia: congenital sex-linked disease -Hemophilia A: absence factor VIII. -Hemophilia B: absence factor IX. -Hemophilia C: absence factor XI.

More Related